Lantheus Holdings (LNTH) Capital Expenditures (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Capital Expenditures of $3.2 million for Q1 2026, down 44.9% year-over-year from $5.9 million in Q1 2025, and down 89.52% quarter-over-quarter from $30.8 million in Q4 2025.
Lantheus Holdings (LNTH) Capital Expenditures (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Capital Expenditures for 13 consecutive years, with $3.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures fell 44.9% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $33.5 million (up 724.14% YoY), while the FY2025 annual figure was $36.1 million, up 613.5% from the prior year.
- Capital Expenditures retreated to $3.2 million in Q1 2026 per LNTH's latest filing, from $30.8 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $47.0 million in Q3 2024 and bottomed at -$75.9 million in Q4 2024.
- Historically, Capital Expenditures has averaged $4.1 million across 5 years, with a median of $5.9 million in 2025.
- On a YoY basis, Capital Expenditures climbed as much as 438.25% in 2023 and fell as far as 309.12% in 2023.
- Lantheus Holdings' Capital Expenditures stood at $18.3 million in 2022, then slumped by 309.12% to -$38.4 million in 2023, then plunged by 97.7% to -$75.9 million in 2024, then soared by 140.57% to $30.8 million in 2025, then tumbled by 89.52% to $3.2 million in 2026.
- Business Quant data shows LNTH's Capital Expenditures at $3.2 million in Q1 2026, $30.8 million in Q4 2025, and $5.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.16 Bn | 43.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.86 Bn | 40.20 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 32.53 Bn | 30.86 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.84 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.34 Bn | 19.68 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.89 Bn | 18.00 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.54 Bn | 15.15 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.95 Bn | 11.42 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Lantheus Holdings | 6.53 Bn | 5.93 Bn | 241.86 Mn | 2.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.34 Mn |
| Jun 30, 2026 | 2.34 Mn |
| Mar 31, 2026 | 3.23 Mn |
| Mar 31, 2026 | 3.23 Mn |
| Dec 31, 2025 | 30.77 Mn |
| Dec 31, 2025 | 30.77 Mn |
| Sep 30, 2025 | 5.32 Mn |
| Sep 30, 2025 | 5.32 Mn |
| Jun 30, 2025 | -5.86 Mn |
| Jun 30, 2025 | -5.86 Mn |
| Mar 31, 2025 | 5.86 Mn |
| Mar 31, 2025 | 5.86 Mn |
| Dec 31, 2024 | -75.85 Mn |
| Dec 31, 2024 | -75.85 Mn |
| Sep 30, 2024 | 47.00 Mn |
| Sep 30, 2024 | 47.00 Mn |
| Jun 30, 2024 | 27.06 Mn |
| Jun 30, 2024 | 27.06 Mn |
| Mar 31, 2024 | 6.85 Mn |
| Mar 31, 2024 | 6.85 Mn |